Search by Drug Name or NDC

    NDC 15370-0130-02 RyVent 6 mg/1 Details

    RyVent 6 mg/1

    RyVent is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Carwin Pharmaceutical Associates, LLC. The primary component is CARBINOXAMINE MALEATE.

    Product Information

    NDC 15370-0130
    Product ID 15370-130_0e84f4a5-7637-6b55-e063-6294a90a4d55
    Associated GPIs 41200010150325
    GCN Sequence Number 077160
    GCN Sequence Number Description carbinoxamine maleate TABLET 6 MG ORAL
    HIC3 Z2P
    HIC3 Description ANTIHISTAMINES - 1ST GENERATION
    GCN 43082
    HICL Sequence Number 004483
    HICL Sequence Number Description CARBINOXAMINE MALEATE
    Brand/Generic Brand
    Proprietary Name RyVent
    Proprietary Name Suffix n/a
    Non-Proprietary Name carbinoxamine maleate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 6
    Active Ingredient Units mg/1
    Substance Name CARBINOXAMINE MALEATE
    Labeler Name Carwin Pharmaceutical Associates, LLC
    Pharmaceutical Class Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207484
    Listing Certified Through 2025-12-31

    Package

    NDC 15370-0130-02 (15370013002)

    NDC Package Code 15370-130-02
    Billing NDC 15370013002
    Package 2 TABLET in 1 BOTTLE, PLASTIC (15370-130-02)
    Marketing Start Date 2017-02-17
    NDC Exclude Flag N
    Pricing Information N/A